Boardroom Alpha
Meeting calendar
CWK · Special meeting · Thursday, October 16, 2025

Cushman & Wakefield Ltd

9 nominees · 10 ballot items.

Proposals to approve the Scheme of Arrangement to redomicile Cushman & Wakefield to Bermuda, related capital reductions and Articles amendments, the issuance of New Cushman & Wakefield Shares, and non-binding governance advisory resolutions, including declassification of the Board, a lower threshold for mergers and the authorization of preference shares, plus adjournment provisions at each meeting.

Market cap
$3.2B
1Y TSR
+25.0%
Board grade
B-
Record date
Aug 29, 2025
Filing
DEF 14A
Meeting concluded · Oct 16, 2025

Follow how the vote landed and what changed on Cushman & Wakefield Ltd’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.

Proposals

On the ballot10

  1. 1

    Court Meeting Resolution No. 1: Approval of Scheme

    ManagementBoard: FOR

    Approve the Scheme of Arrangement to implement Cushman & Wakefield’s Redomiciliation to Bermuda (Court approval required).

  2. 2

    Scheme Resolution No. 1: Approval of Scheme (General Meeting

    ManagementBoard: FOR

    Approve the Scheme and authorize actions needed to implement it.

  3. 3

    Scheme Resolution No. 2: Cushman & Wakefield Reduction of Capital

    ManagementBoard: FOR

    Authorize the reduction of share capital to cancel Scheme Shares and fund New Cushman & Wakefield Shares.

  4. 4

    Scheme Resolution No. 3: Articles Amendments

    ManagementBoard: FOR

    Amend the Articles to facilitate the Scheme, including creation of a new class of B Ordinary Shares and tying new shares into the Scheme.

  5. 5

    Scheme Resolution No. 4: Issue of New Shares to New Cushman & Wakefield

    ManagementBoard: FOR

    Approve the issue of New Cushman & Wakefield Shares to Scheme Shareholders and the resulting control of Cushman & Wakefield by New Cushman & Wakefield.

  6. 6

    General Meeting Adjournment

    ManagementBoard: FOR

    Approve adjournment of the General Meeting if necessary to solicit additional votes.

  7. 7

    Board Declassification (Shareholders Meeting Advisory Resolution 1

    ManagementBoard: FOR

    Non-binding advisory on declassification of the New Cushman & Wakefield Board (annual elections after a transition).

  8. 8

    Business Combinations (Shareholders Meeting Advisory Resolution 2

    ManagementBoard: FOR

    Non-binding advisory on the threshold for mergers and business combinations under the New Cushman & Wakefield Bye-laws.

  9. 9

    Authorization of Preference Shares (Shareholders Meeting Advisory Resolution 3

    ManagementBoard: FOR

    Non-binding advisory on authorizing the issuance of preference shares under the New Cushman & Wakefield Bye-laws.

  10. 10

    Shareholders Meeting Adjournment

    ManagementBoard: FOR

    Adjournment of the Shareholders Meeting if necessary to solicit additional votes.

Director elections

Nominees on the ballot9

Independent
Tenure on this board
8.0 yrs
Also a director at
Pentair PLC (PNR)Cricut Inc (CRCT)
Independent
Tenure on this board
0.9 yrs
Also a director at
Pubmatic Inc (PUBM)
Independent
Tenure on this board
2.7 yrs
Also a director at
Acacia Research Corp (ACTG)
Independent
Tenure on this board
2.3 yrs
Also a director at
Cboe Global Markets Inc (CBOE)
Independent
Tenure on this board
4.7 yrs
Also a director at
Western Union Co (WU)
Not independent
Tenure on this board
0.9 yrs
Also a director at
Upstart Holdings Inc (UPST)
Ownership

Top institutional holders10

Latest 13F quarter
1VANGUARD PORTFOLIO MANAGEMENT LLC10.4%24,366,565$299M
2BlackRock, Inc.7.3%17,077,177$209M
3DIMENSIONAL FUND ADVISORS LP5.4%12,583,205$154M
4VANGUARD CAPITAL MANAGEMENT LLC4.4%10,388,259$127M
5STATE STREET CORP3.9%9,132,316$112M
6FMR LLC2.7%6,230,941$76M
7Channing Capital Management, LLC2.3%5,460,628$67M
8GEODE CAPITAL MANAGEMENT, LLC2.3%5,335,184$65M
9Eurizon Capital SGR S.p.A.2.1%4,989,906$61M
10VICTORY CAPITAL MANAGEMENT INC2.1%4,839,540$59M
Filings

Recent key filings

Periodic reports
Definitive proxies
Reference

Frequently asked questions

When is the Cushman & Wakefield Ltd 2025 special meeting?
Cushman & Wakefield Ltd (CWK) holds its 2025 special shareholder meeting on Thursday, October 16, 2025.
What is the record date for the Cushman & Wakefield Ltd 2025 meeting?
The record date for the Cushman & Wakefield Ltd 2025 meeting is Friday, August 29, 2025. Shareholders of record on or before that date are eligible to vote.
Who are the director nominees for Cushman & Wakefield Ltd's 2025 meeting?
The board is presenting 9 director nominees at the Cushman & Wakefield Ltd 2025 meeting, listed with their independence status and background.
What proposals will shareholders vote on at the Cushman & Wakefield Ltd 2025 meeting?
Shareholders will vote on 10 proposals at the Cushman & Wakefield Ltd 2025 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer